Evidence map›Paper›PMID 22198211›Full record

ReviewCarcinogenesis2012

Modulation of Wnt/β-catenin signaling pathway by bioactive food components.

Rohinton S Tarapore, Imtiaz A Siddiqui, Hasan Mukhtar

Open access · bronzeAbstract readReview
In one paragraph

Review in Carcinogenesis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 112 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Evolutionary conservation and cancer implications of the WNT signaling pathway.Medical oncology (Northwood, London, England) · 2025
    Review
  6. Article
  7. Review
  8. Effect of bioactive compounds ofIn silico pharmacology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in pharmacology · 2022
    Article
  13. Article
  14. Article
  15. A Comparative Study on Anticancer Effects of theEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  16. Article
  17. Nature-derived compounds modulating Wnt/Acta pharmaceutica Sinica. B · 2020
    Review
  18. WNT Signaling in Melanoma.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rohinton S TaraporeDepartment of Dermatology, School of Medicine and Public Health, University of Wisconsin, Medical Sciences Center, #B-25, 1300 University Avenue, Madison, WI 53706, USA.
Imtiaz A Siddiqui
Hasan Mukhtar
University of Wisconsin–Madison · USUniversity of Pennsylvania · US

Funding

Developing Fisetin for the Managment of Prostate CancerR01CA160867 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MUKHTAR, HASAN · 2011 to 2015
$1.6M
Investigative Dermatology Training Program at University of Wisconsin-MadisonT32AR055893 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI MUKHTAR, HASAN · 2009 to 2013
$984k
NCI NIH HHS R01 CA 160867NCI NIH HHS R01 CA160867NIAMS NIH HHS T32AR055893
6 · The paper itself

Abstract

The Wnt/β-catenin signaling pathway, one of the most conserved intercellular signaling cascade, is a known regulator of cellular functions related to tumor initiation and progression, cell proliferation, differentiation, survival and adhesion. Because aberrant Wnt/β-catenin signaling has been observed in a variety of human cancers including a majority of colorectal cancers, about half of prostate cancers and a third of melanomas, inhibitors of its complex signaling pathways are being investigated for therapy as well as chemoprevention of these cancers. During the last decade, several naturally occurring dietary agents have been shown to target intermediates in the Wnt/β-catenin signaling pathway. In this review, we highlight the current understanding of the Wnt/β-catenin signaling pathway and present an analysis of the key findings from laboratory studies on the effects of a panel of dietary agents against a variety of cancers. Promise of these agents for treating and preventing human cancer is then discussed.

Indexed as

AnimalsAntineoplastic Agents, Phytogenicbeta CateninBiological ProductsCell Line, TumorCell ProliferationCell Transformation, NeoplasticColorectal NeoplasmsFoodHumansIntercellular Signaling Peptides and ProteinsMaleMelanomaNeoplasmsPhytotherapyProstatic NeoplasmsAntineoplastic Agents, Phytogenicbeta CateninBiological ProductsCTNNB1 protein, humanIntercellular Signaling Peptides and ProteinsWnt Proteins

Identifiers

PMID22198211
PMCPMC3384069
OpenAlexW2157744430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.